First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

Unger ER, Lin JS, Wisk LE, Yu H, L'Hommedieu M, Lavretsky H, Montoy JCC, Gottlieb MA, Rising KL, Gentile NL, Santangelo M, Venkatesh AK, Rodriguez[...]

Xia J, Ahmed R. Rapidly progressive locked-in syndrome secondary to atypical herpes simplex virus-1 rhombencephalitis in an immunocompromised individual. IDCases. 2024 Jul 6;37:e02027. doi: 10.1016/j.idcr.2024.e02027.[...]

Quigley DD, Elliott MN, Qureshi N, Predmore Z, Hays RD. How the CAHPS Clinician and Group Patient Experience Survey Data Have Been Used in Research:[...]